Kyowa Kirin (OTCMKTS:KYKOF) Shares Down 14.9% – Time to Sell?

Kyowa Kirin Co., Ltd. (OTCMKTS:KYKOFGet Free Report)’s share price traded down 14.9% during mid-day trading on Monday . The company traded as low as $12.32 and last traded at $12.32. 375 shares were traded during trading, an increase of 19% from the average session volume of 315 shares. The stock had previously closed at $14.47.

Kyowa Kirin Stock Performance

The stock’s 50-day moving average is $14.84 and its 200-day moving average is $17.48.

Kyowa Kirin Company Profile

(Get Free Report)

Kyowa Kirin Co, Ltd. engages in the research, development, manufacturing, marketing, and import/export of pharmaceuticals for oncology, nephrology, central nervous system, and immunology therapeutic areas in Japan, the United States, rest of the Americas, Europe, Asia, and internationally. Its products include ALLELOCK, an antihistamine agent for patients with various types of allergies; CONIEL, a calcium channel blocker for hypertension and angina pectoris; Crysvita, a recombinant human monoclonal IgG1 antibody against the phosphaturic hormone fibroblast growth factor 23; ESPO, a glycoprotein and human erythropoietin; NESP, an erythropoiesis stimulating agent; and GRAN, a human colony-stimulating factor.

Read More

Receive News & Ratings for Kyowa Kirin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kyowa Kirin and related companies with MarketBeat.com's FREE daily email newsletter.